As shown in Figure 1D, the combined LUT and I3C synergistically inhibited ER+ breast cancer cells MCF7 and T47D cell growth only, whereas no synergistic effects were observed in TNBC BT-549 and MDA-MB-231 cells at the ranges of the selected concentrations. Here, ESR1 is linked to breast carcinoma.